Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Research & Development: 2019-2025

Historic Research & Development for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to $18.3 million.

  • Benitec Biopharma's Research & Development fell 18.37% to $2.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.3 million, marking a year-over-year increase of 17.45%. This contributed to the annual value of $18.3 million for FY2025, which is 17.45% up from last year.
  • Benitec Biopharma's Research & Development amounted to $18.3 million in FY2025, which was up 17.45% from $15.6 million recorded in FY2024.
  • Over the past 5 years, Benitec Biopharma's Research & Development peaked at $18.3 million during FY2025, and registered a low of $7.0 million during FY2021.
  • Moreover, its 3-year median value for Research & Development was $15.6 million (2024), whereas its average is $15.6 million.
  • Data for Benitec Biopharma's Research & Development shows a peak YoY soared of 133.92% (in 2021) over the last 5 years.
  • Over the past 5 years, Benitec Biopharma's Research & Development (Yearly) stood at $7.0 million in 2021, then spiked by 60.57% to $11.3 million in 2022, then rose by 13.33% to $12.8 million in 2023, then rose by 22.19% to $15.6 million in 2024, then grew by 17.45% to $18.3 million in 2025.